dc.contributor.authors |
Mutlu, O ; Ulak, G ; Celikyurt, IK ; Akar, FY ; Erden, F ; Tanyeri, P |
|
dc.date.accessioned |
2020-02-27T08:33:45Z |
|
dc.date.available |
2020-02-27T08:33:45Z |
|
dc.date.issued |
2011 |
|
dc.identifier.citation |
Mutlu, O ; Ulak, G ; Celikyurt, IK ; Akar, FY ; Erden, F ; Tanyeri, P (2011). Effects of olanzapine, sertindole and clozapine on MK-801 induced visual memory deficits in mice. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, , 565-557 |
|
dc.identifier.issn |
0091-3057 |
|
dc.identifier.uri |
https://doi.org/10.1016/j.pbb.2011.06.011 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12619/66407 |
|
dc.description.abstract |
Male Balb-c mice were treated with olanzapine (0.2.0.4 and 0.6 mg/kg; i.p.), sertindole (0.63,1.3 and 2.5 mg/kg; s.c.) or clozapine (0.5 and 1 mg/kg; i.p.). and cognitive deficits were induced by MK-801 (0.2 mg/kg; i.p.) administration. Olanzapine treatment decreased the ratio index in the NOR test, whereas sertindole anti clozapine had no effect in naive mice. MK-801-induced cognitive impairment was reversed by treatment with olanzapine, sertindole or clozapine. While olanzapine. sertindole and clozapine had no effect on the anxiety of naive mice as determined by the open field test, MK-801 significantly increased the total distance traveled, time spent in the center zone and the velocity of the animals. MK-801-induced effects on locomotion and anxiety in the open field test were reversed by olanzapine, sertindole or clozapine treatment. The results of the present study demonstrated that olanzapine, sertindole and clozapine improved cognition in MK-801 treated mice, and indicate that these drugs have a potential to improve cognition in schizophrenia. (C) 2011 Elsevier Inc. All rights reserved. |
|
dc.language |
English |
|
dc.publisher |
PERGAMON-ELSEVIER SCIENCE LTD |
|
dc.subject |
Pharmacology & Pharmacy |
|
dc.title |
Effects of olanzapine, sertindole and clozapine on MK-801 induced visual memory deficits in mice |
|
dc.type |
Article |
|
dc.identifier.startpage |
557 |
|
dc.identifier.endpage |
565 |
|
dc.contributor.department |
Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü |
|
dc.contributor.saüauthor |
Tanyeri, Pelin |
|
dc.relation.journal |
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR |
|
dc.identifier.wos |
WOS:000294880100006 |
|
dc.identifier.doi |
10.1016/j.pbb.2011.06.011 |
|
dc.contributor.author |
Tanyeri, Pelin |
|